Perspective Therapeutics (CATX) Operating Margin (2010 - 2023)
Perspective Therapeutics (CATX) posted Operating Margin of 238.19% for Q4 2023, up 153.38% sequentially from 446.22% in Q3 2023.
Perspective Therapeutics (CATX) Operating Margin (2010 - 2023) Analysis & Trends
Perspective Therapeutics has reported Operating Margin for 14 years, with the latest figure at 238.19% in Q4 2023.
- Quarterly Operating Margin changed N/A year-over-year to 238.19% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 4839.36% (changed N/A YoY) and the FY2023 annual result came in at 2855.02%, changed N/A from the prior year.
- Operating Margin improved to 238.19% in Q4 2023 per CATX's latest filing, from 446.22% in the prior quarter.
- Over five years, Operating Margin peaked at 238.19% in Q4 2023 and troughed at 650.27% in Q2 2023.
- A 5-year average of 105.92% and a median of 52.17% in 2020 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2021 and 2023: Operating Margin jumped 10184 bps in 2021, then tumbled 58596 bps in 2023.
- Over 5 years, Operating Margin stood at 40.93% in 2019, then climbed by 10 bps to 37.01% in 2020, then plunged by 57 bps to 58.06% in 2021, then tumbled by 86 bps to 107.82% in 2022, then soared by 321 bps to 238.19% in 2023.
- According to Business Quant data, Operating Margin over the past three periods registered 238.19%, 446.22%, and 650.27% for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.18 Bn | 195.57 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 126.42 Bn | 122.95 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.89 Bn | 109.67 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.48 Bn | 72.94 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.75 Bn | 47.50 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.66 Bn | 32.71 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.69 Bn | 31.58 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 19.15% |
| 10 | Perspective Therapeutics | 412.02 Mn | 412.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 238.19% |
| Sep 30, 2023 | -446.22% |
| Jun 30, 2023 | -650.27% |
| Mar 31, 2023 | -473.15% |
| Sep 30, 2022 | -107.82% |
| Jun 30, 2022 | -64.30% |
| Mar 31, 2022 | -47.29% |
| Dec 31, 2021 | -58.06% |
| Sep 30, 2021 | -88.69% |
| Jun 30, 2021 | 49.67% |
| Mar 31, 2021 | -29.46% |
| Dec 31, 2020 | -37.01% |
| Sep 30, 2020 | -29.95% |
| Jun 30, 2020 | -52.17% |
| Mar 31, 2020 | -19.03% |
| Dec 31, 2019 | -40.93% |
| Sep 30, 2019 | -36.11% |
| Jun 30, 2019 | -59.46% |
| Mar 31, 2019 | -60.45% |
| Dec 31, 2018 | -75.05% |